Inhibikase Therapeutics, Inc. — 10-K Filings
6 10-K filings on record
This page lists all 10-K filings submitted to the SEC by Inhibikase Therapeutics, Inc. (IKT), sorted by most recent first. Each row links to the full filing on EdgarLookup. Inhibikase Therapeutics, Inc. has filed 6 10-K documents with the SEC since 2018. To view all SEC filings by Inhibikase Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
PRE 14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13G
SC 13G/A
SC 14F1
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-K | 10-K | 0001193125-26-126371 | Mar 26, 2026 | Dec 31, 2025 |
| 10-K | 10-K | 0000950170-25-046096 | Mar 27, 2025 | Dec 31, 2024 |
| 10-K | 10-K | 0000950170-24-037160 | Mar 27, 2024 | Dec 31, 2023 |
| 10-K | 10-K | 0000950170-23-011133 | Mar 31, 2023 | Dec 31, 2022 |
| 10-K | 10-K | 0000950170-22-005203 | Mar 31, 2022 | Dec 31, 2021 |
| 10-K | 10-K | 0001564590-21-016996 | Mar 31, 2021 | Dec 31, 2020 |